Selecta seeks $30M in secondary offering to focus on gout drug
The news comes a few weeks after the company said it would cut more than a third of its employees and shelve a cancer drug following various trial problems late last year.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Gintautas Dumcius Source Type: news